Sponsored Content
Intercell Completes Equity Private Placement
The Austrian pharmaceutical company raises funds of € 15.2m at a price of € 2.30 per new share - bringing total volume of combined debt and equity financing to € 35.2m.

Intercell AG today announced that it successfully completed a previously announced financing transaction consisting of a € 20.0m secured loan (the "Term Loan") provided by BB Biotech and an equity private placement (the "Private Placement") of approximately € 15.2m. The Intercell shares were placed at an adjusted price of € 2.30, corresponding to the opening share price of…
or Log In
Fast News Search